1. Home
  2. LYEL vs GRABW Comparison

LYEL vs GRABW Comparison

Compare LYEL & GRABW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYEL
  • GRABW
  • Stock Information
  • Founded
  • LYEL 2018
  • GRABW 2012
  • Country
  • LYEL United States
  • GRABW Singapore
  • Employees
  • LYEL N/A
  • GRABW 11267
  • Industry
  • LYEL Biotechnology: Pharmaceutical Preparations
  • GRABW Business Services
  • Sector
  • LYEL Health Care
  • GRABW Consumer Discretionary
  • Exchange
  • LYEL Nasdaq
  • GRABW Nasdaq
  • Market Cap
  • LYEL 207.7M
  • GRABW N/A
  • IPO Year
  • LYEL 2021
  • GRABW N/A
  • Fundamental
  • Price
  • LYEL $12.43
  • GRABW $0.52
  • Analyst Decision
  • LYEL Sell
  • GRABW
  • Analyst Count
  • LYEL 2
  • GRABW 0
  • Target Price
  • LYEL $15.00
  • GRABW N/A
  • AVG Volume (30 Days)
  • LYEL 25.4K
  • GRABW 54.7K
  • Earning Date
  • LYEL 11-06-2025
  • GRABW 02-21-2025
  • Dividend Yield
  • LYEL N/A
  • GRABW N/A
  • EPS Growth
  • LYEL N/A
  • GRABW N/A
  • EPS
  • LYEL N/A
  • GRABW N/A
  • Revenue
  • LYEL $60,000.00
  • GRABW $2,686,000,000.00
  • Revenue This Year
  • LYEL N/A
  • GRABW N/A
  • Revenue Next Year
  • LYEL N/A
  • GRABW N/A
  • P/E Ratio
  • LYEL N/A
  • GRABW N/A
  • Revenue Growth
  • LYEL 11.11
  • GRABW 21.65
  • 52 Week Low
  • LYEL $7.65
  • GRABW $0.15
  • 52 Week High
  • LYEL $32.00
  • GRABW $0.59
  • Technical
  • Relative Strength Index (RSI)
  • LYEL 57.06
  • GRABW 70.51
  • Support Level
  • LYEL $11.93
  • GRABW $0.43
  • Resistance Level
  • LYEL $13.62
  • GRABW $0.55
  • Average True Range (ATR)
  • LYEL 0.69
  • GRABW 0.05
  • MACD
  • LYEL 0.02
  • GRABW 0.02
  • Stochastic Oscillator
  • LYEL 63.01
  • GRABW 86.80

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Share on Social Networks: